SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-23-051737
Filing Date
2023-10-03
Accepted
2023-10-03 20:03:35
Documents
2
Period of Report
2023-10-02

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1565
2 EX-24.1 rgen-ex24_1.htm EX-24.1 6771
  Complete submission text file 0000950170-23-051737.txt   9750
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Issuer) CIK: 0000730272 (see all company filings)

IRS No.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O REPLIGEN CORPORATION 41 SEYON STREET, BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address
Loeillot Olivier (Reporting) CIK: 0001995525 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-14656 | Film No.: 231306234